(Q51938718)

18 April 2018

title

Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. (English)

1 reference

18 April 2018

neuroleptic malignant syndrome

1 reference

1 reference

Jambur Ananth

1

1 reference

18 April 2018

Kamala Aduri

series ordinal

2

1 reference

18 April 2018

Sharath Parameswaran

series ordinal

3

1 reference

18 April 2018

Sarath Gunatilake

series ordinal

4

1 reference

18 April 2018

publication date

1 August 2004

1 reference

18 April 2018

published in

Acta Neuropsychiatrica

1 reference

18 April 2018

volume

16

1 reference

18 April 2018

issue

4

1 reference

18 April 2018

page(s)

219-228

1 reference

18 April 2018

Dantrolene Prevents Glutamate Cytotoxicity and Ca2+Release from Intracellular Stores in Cultured Cerebral Cortical Neurons

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Presynaptic dopaminergic modulation of cortical input to the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Fluoxetine and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Haloperidol and thyroid storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Amoxapine - An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Thermoregulatory dysfunction in neuroleptic malignant syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Management of suspected neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Amoxapine: neuroleptic as well as antidepressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Successful Treatment of Levodopa-induced Neuroleptic Malignant Sydrome(NMS) and Disseminated Intravascular Coagulation(DIC) in a Patient with Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Sympathoadrenomedullary activity in the neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

A prospective analysis of 24 episodes of neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

The neuroleptic malignant syndrome: review and report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

The neuroleptic malignant syndrome: agent and host interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Long-lasting neurological sequelae after lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome: review and analysis of 115 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Clinical management of neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Is the Predisposition to Neuroleptic Malignant Syndrome Genetically Transmitted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome: observations on altered consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome: A complication of neuroleptics and cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Iron status, movement disorders, and acute phase response in elderly psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome after venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome due to promethazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Neuroleptic malignant syndrome associated with diphenhydramine and diprophyllin overdose in a depressed patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

"Non-neuroleptic malignant" syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Effects of cerebral hemispheric laterality on the span of apprehension of schizophrenic and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Benzodiazepines and catatonia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Frequency and presentation of neuroleptic malignant syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

Sensory ataxia as the initial clinical symptom in X-linked recessive bulbospinal neuronopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0924-2708.2004.00085.X

10.1111/J.0924-2708.2004.00085.X

21 January 2018

Identifiers

DOI

1 reference

18 April 2018

release_hrxfmxkwfzh4nezoavopydtwfi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hrxfmxkwfzh4nezoavopydtwfi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 April 2018